NASDAQ:ABMD

Abiomed - ABMD News Today

Notice: This company has been marked as potentially delisted and may not be actively trading.

Add

Compare

Today's Range: $381.02
▼
$381.02
50-Day Range: $377.20
▼
$381.30
52-Week Range: $219.85
▼
$381.99

Volume: 258 shs
Average Volume: 611,028 shs
Market Capitalization: $17.18 billion

P/E Ratio: 65.47
Dividend Yield: N/A
Price Target: $355.60

Institutional Ownership

Get Abiomed News Delivered to You Automatically

ABMD Media Mentions By Week

ABMD Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ABMD
News Sentiment
▼
0.44

0.34
▲
Average
Medical
News Sentiment

ABMD News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ABMD Articles
This Week
▼
2

4
▲
ABMD Articles
Average Week

Source

Source	Headline
	Want to Retire a Millionaire? 2 Stocks to Buy Now stocknews.com - March 21 at 11:42 AM
	3 Stocks That Could Deliver Healthy Returns in 2023 stocknews.com - March 17 at 5:31 PM
	This Big Pharma Stock Is a Clear Buy in 2023 stocknews.com - March 13 at 3:22 PM
	Abiomed, Inc. (ABMD) stock historical prices & data – Yahoo Finance uk.finance.yahoo.com - March 12 at 11:26 AM
	3 Powerhouse Stocks to Buy in 2023 stocknews.com - March 10 at 9:22 AM
	3 Hot Dividend Stocks to Buy Now and Hold Forever stocknews.com - March 6 at 4:53 PM
	Abiomed, Inc. (ABMD) Stock Historical Prices & Data - Yahoo Finance finance.yahoo.com - March 4 at 6:21 PM
	2 No-Brainer Warren Buffett Stocks to Buy in 2023 stocknews.com - March 2 at 11:58 AM
	3 S&P 500 Stocks to Buy If You Like Winning stocknews.com - March 1 at 12:37 PM
	3 Stocks to Help Grow Your Portfolio Over the Next Decade stocknews.com - February 28 at 2:37 PM
	3 Reasons to Retain Abiomed (ABMD) Stock in Your Portfolio finance.yahoo.com - December 22 at 1:25 PM
	FDA Approves Impella ECP Pivotal Heart Pump and First Patients Enrolled in Pivotal Clinical Trial finance.yahoo.com - December 21 at 9:08 AM
	10 Best Performing Stocks in November finance.yahoo.com - December 13 at 1:06 PM
	This Monster Dividend Stock Isn't Done Growing finance.yahoo.com - December 8 at 10:13 AM
	First Patients in the World Treated with Impella RP Flex with SmartAssist finance.yahoo.com - December 5 at 6:10 PM
	Why Is Abiomed (ABMD) Up 1.2% Since Last Earnings Report? finance.yahoo.com - December 1 at 5:43 PM
	Johnson & Johnson Could Level Up With Its $16.8 Billion Purchase of Abiomed finance.yahoo.com - November 10 at 5:27 PM
	Johnson & Johnson's Big Purchase, Amazon's New Moves, and More finance.yahoo.com - November 5 at 12:41 PM
	Abiomed (ABMD) Q2 Earnings Top Estimates, Margins Down finance.yahoo.com - November 1 at 2:39 PM
	Is Abiomed (ABMD) a Solid Growth Stock? 3 Reasons to Think "Yes" finance.yahoo.com - October 29 at 11:12 AM
	Abiomed Creates Patient Assistance Program to Address Disparities in Healthcare nz.finance.yahoo.com - October 26 at 8:49 AM
	Ventricular Assist Devices Market Report (2022 to 2030) - Abiomed, Inc., Medtronic Plc, Abbott Laboratori - Benzinga benzinga.com - October 19 at 11:37 PM
	FDA Approves Abiomed's Impella Low Profile Sheath finance.yahoo.com - October 17 at 9:11 PM
	Abiomed Announces U.S. FDA Grants 510(k) Clearance For Impella Low Profile Sheath - Abiomed (NASDAQ:ABMD) - Benzinga benzinga.com - October 17 at 10:07 AM
	Abiomed (ABMD) Announces U.S. FDA Grants 510(k) Clearance for Impella Low Profile Sheath - StreetInsider.com streetinsider.com - October 17 at 10:07 AM
	U.S. FDA Grants 510(k) Clearance for Impella Low Profile Sheath finance.yahoo.com - October 17 at 10:07 AM
	Yale University Study Demonstrates Significant Survival Benefit in High-Risk PCI with Impella Support - Business Wire businesswire.com - October 13 at 3:15 PM
	Abiomed Second Quarter Fiscal 2023 Earnings and Conference Call Notification - Abiomed (NASDAQ:ABMD) - Benzinga benzinga.com - October 13 at 10:15 AM
	Walgreens (WBA) to Report Q4 Earnings: What's in the Cards? - Nasdaq nasdaq.com - October 10 at 2:22 PM
	AngioDynamics (ANGO) Q1 Earnings, Revenues Lag Estimates - Nasdaq nasdaq.com - October 10 at 2:22 PM
	Abiomed (ABMD) is an Incredible Growth Stock: 3 Reasons Why - Nasdaq nasdaq.com - October 7 at 8:39 PM
	Here's Why You Should Retain DENTSPLY SIRONA (XRAY) Stock Now - Nasdaq nasdaq.com - October 7 at 3:10 PM
	Neogen (NEOG) Q1 Earnings Top Estimates, Operating Margin Dips - Nasdaq nasdaq.com - October 7 at 3:10 PM
	Edwards Lifesciences (EW) TAVR Sales Strong Amid Macro Issues - Nasdaq nasdaq.com - October 7 at 3:10 PM
	Abiomed (ABMD) is an Incredible Growth Stock: 3 Reasons Why finance.yahoo.com - October 7 at 3:10 PM
	Abiomed, Inc. (NASDAQ:ABMD) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap? nasdaq.com - September 28 at 3:16 PM
	Medical device maker Abiomed doubles revenue in five years - Boston Business Journal - The Business Journals bizjournals.com - September 23 at 12:18 PM
	Ventricular Assist Device Global Market Report 2022 - Yahoo Finance finance.yahoo.com - September 22 at 1:45 PM
	Abiomed (ABMD) Posts Impellas Positive Study Results in Japan - Nasdaq nasdaq.com - September 21 at 12:39 PM
	Unloading with Impella for 30 Minutes Before PCI Associated with Reduced Infarct Size in STEMI Patients - Business Wire businesswire.com - September 19 at 11:31 AM
	Abiomed (ABMD) Announces Large, Multi-Center, Multi-Society Study of Impella-supported Patients Finds 30-day AMI Cardiogenic Shock Survival of 81% - StreetInsider.com streetinsider.com - September 19 at 11:31 AM
	Abiomed (ABMD) Announces FDA Approval of RECOVER IV Trial with Exception from EFIC - StreetInsider.com streetinsider.com - September 16 at 9:32 AM
	U.S. FDA gives two approvals to Abiomed Impella heart pumps - Seeking Alpha seekingalpha.com - September 16 at 9:32 AM
	FDA Approves RECOVER IV Randomized Controlled Trial with Exception from Informed Consent (EFIC) finance.yahoo.com - September 16 at 9:32 AM
	TCT 2022: Impella Enables Complete Revascularization, Improved Quality of Life and Native Heart Recovery - Business Wire businesswire.com - September 14 at 12:05 AM
	Abiomed (NASDAQ:ABMD) – TCT 2022: Impella Enables Complete Revascularization, Improved Quality of Life and Native Heart Recovery - Benzinga benzinga.com - September 13 at 8:54 AM
	3 Reasons to Hold Abiomed (ABMD) Stock in Your Portfolio - Nasdaq nasdaq.com - September 2 at 10:41 PM
	3 Reasons to Hold Abiomed (ABMD) Stock in Your Portfolio - Yahoo Finance finance.yahoo.com - September 2 at 5:39 PM
	MBTA Safety Report Reaction and Abiomed CEO - Bloomberg bloomberg.com - September 1 at 2:42 AM
	Tuesday Sector Leaders: Healthcare, Financial - Nasdaq nasdaq.com - August 31 at 6:40 AM

Get Abiomed News Delivered to You Automatically

This page (NASDAQ:ABMD) was last updated on 3/22/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Abiomed - ABMD News Today

ABMD Media Mentions By Week

ABMD Media Sentiment

ABMD News Coverage

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info